2044-5040

Skeletal Muscle

Springer (Biomed Central Ltd.)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 382 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact382 DOIs
2

Add abstracts to 288 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact288 DOIs
3

Add license metadata to 173 records

License metadata tells indexers and readers how each article may be reused.

Medium impact173 DOIs

DOIs for this ISSN

Showing the top 5 of 523 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Regulation of skeletal muscle growth by the IGF1-Akt/PKB pat… (10.1186/2044-5040-1-4)
Abstract References ORCID License
283.06 676
2 Skeletal muscle proteomics: current approaches, technical ch… (10.1186/2044-5040-1-6)
Abstract References ORCID License
200.43 100
3 Incidence and severity of myofiber branching with regenerati… (10.1186/2044-5040-4-9)
Abstract References ORCID License
179.93 62
4 SMASH – semi-automatic muscle analysis using segmentation of… (10.1186/2044-5040-4-21)
Abstract ORCID License
176.56 225
5 Role of TGF-β signaling in inherited and acquired myopathies (10.1186/2044-5040-1-19)
Abstract ORCID License
174.01 208
6 T-tubule biogenesis and triad formation in skeletal muscle a… (10.1186/2044-5040-1-26)
Abstract ORCID License
165.91 162
7 Facioscapulohumeral dystrophy: the path to consensus on path… (10.1186/2044-5040-4-12)
Abstract ORCID License
163.85 152
8 The muscle satellite cell at 50: the formative years (10.1186/2044-5040-1-28)
Abstract ORCID License
162.77 147
9 Treating cancer cachexia to treat cancer (10.1186/2044-5040-1-2)
Abstract References ORCID License
162.32 41
10 Kelch proteins: emerging roles in skeletal muscle developmen… (10.1186/2044-5040-4-11)
Abstract ORCID License
161.88 143
11 The myogenic kinome: protein kinases critical to mammalian s… (10.1186/2044-5040-1-29)
Abstract ORCID License
159.53 133
12 The golden retriever model of Duchenne muscular dystrophy (10.1186/s13395-017-0124-z)
Abstract ORCID License
157.79 126
13 Myostatin blockade with a fully human monoclonal antibody in… (10.1186/s13395-015-0060-8)
Abstract ORCID License
157.53 125
14 The breaking and making of healthy adult human skeletal musc… (10.1186/s13395-017-0142-x)
Abstract ORCID License
152.20 106
15 Long noncoding RNAs, emerging players in muscle differentiat… (10.1186/2044-5040-4-8)
Abstract ORCID License
151.28 103
16 Voluntary resistance wheel exercise from mid-life prevents s… (10.1186/s13395-016-0117-3)
Abstract ORCID License
150.65 101
17 The beneficial role of proteolysis in skeletal muscle growth… (10.1186/s13395-016-0086-6)
Abstract ORCID License
150.32 100
18 ColVI myopathies: where do we stand, where do we go? (10.1186/2044-5040-1-30)
Abstract ORCID License
148.67 95
19 Failed reinnervation in aging skeletal muscle (10.1186/s13395-016-0101-y)
Abstract ORCID License
148.67 95
20 Novel and optimized strategies for inducing fibrosis in vivo… (10.1186/2044-5040-4-7)
Abstract ORCID License
148.33 94
21 Skeletal muscle laminin and MDC1A: pathogenesis and treatmen… (10.1186/2044-5040-1-9)
Abstract ORCID License
147.98 93
22 Alveolar rhabdomyosarcoma – The molecular drivers of PAX3/7-… (10.1186/2044-5040-2-25)
Abstract ORCID License
147.64 92
23 TAK-1/p38/nNFκB signaling inhibits myoblast differentiation… (10.1186/2044-5040-2-3)
Abstract ORCID License
147.28 91
24 A mouse anti-myostatin antibody increases muscle mass and im… (10.1186/s13395-017-0141-y)
Abstract ORCID License
146.57 89
25 Muscle membrane repair and inflammatory attack in dysferlino… (10.1186/2044-5040-1-10)
Abstract ORCID License
142.32 78
26 Aberrant repair and fibrosis development in skeletal muscle (10.1186/2044-5040-1-21)
ORCID License
142.22 698
27 Sequential association of myogenic regulatory factors and E… (10.1186/2044-5040-1-14)
Abstract ORCID License
139.30 71
28 High-throughput screening identifies inhibitors of DUX4-indu… (10.1186/2044-5040-4-4)
Abstract ORCID License
134.43 61
29 Complement C5a-C5aR1 signalling drives skeletal muscle macro… (10.1186/s13395-017-0128-8)
Abstract ORCID License
133.36 59
30 Developmental myosins: expression patterns and functional si… (10.1186/s13395-015-0046-6)
Abstract ORCID
132.76 451
31 Increased plasma lipid levels exacerbate muscle pathology in… (10.1186/s13395-017-0135-9)
Abstract ORCID License
131.69 56
32 Challenges to oligonucleotides-based therapeutics for Duchen… (10.1186/2044-5040-1-8)
Abstract References ORCID License
130.10 19
33 Post-natal induction of PGC-1α protects against severe muscl… (10.1186/2044-5040-4-2)
Abstract ORCID License
129.93 53
34 Myofiber branching rather than myofiber hyperplasia contribu… (10.1186/2044-5040-4-10)
Abstract ORCID License
129.32 52
35 Congenital muscular dystrophy with fatty liver and infantile… (10.1186/s13395-015-0056-4)
Abstract ORCID License
129.32 52
36 p38β MAPK upregulates atrogin1/MAFbx by specific phosphoryla… (10.1186/2044-5040-2-20)
Abstract ORCID License
128.70 51
37 Involvement of adiponectin in the pathogenesis of dystrophin… (10.1186/s13395-015-0051-9)
Abstract ORCID License
128.07 50
38 Linkages between changes in the 3D organization of the genom… (10.1186/s13395-017-0122-1)
Abstract ORCID License
126.09 47
39 Nebulin interactions with actin and tropomyosin are altered… (10.1186/2044-5040-4-15)
Abstract ORCID License
124.71 45
40 Aging impairs contraction-induced human skeletal muscle mTOR… (10.1186/2044-5040-1-11)
ORCID License
124.21 304
41 Immortalized pathological human myoblasts: towards a univers… (10.1186/2044-5040-1-34)
ORCID License
123.42 293
42 Welcome to Skeletal Muscle (10.1186/2044-5040-1-1)
Abstract References ORCID License
123.04 16
43 Inhibition of extracellular signal-regulated kinase 1/2 sign… (10.1186/2044-5040-3-17)
Abstract ORCID License
122.51 42
44 Low-intensity pulsed ultrasound prevents muscle atrophy indu… (10.1186/s13395-017-0145-7)
Abstract ORCID License
121.74 41
45 Chromatin-wide and transcriptome profiling integration uncov… (10.1186/s13395-016-0074-x)
Abstract ORCID License
120.96 40
46 Failed upregulation of TFAM protein and mitochondrial DNA in… (10.1186/s13395-016-0083-9)
Abstract ORCID License
120.96 40
47 Laminin 521 maintains differentiation potential of mouse and… (10.1186/s13395-016-0116-4)
Abstract ORCID License
120.96 40
48 Dysregulation of matricellular proteins is an early signatur… (10.1186/2044-5040-4-14)
Abstract ORCID License
120.15 39
49 From proteins to genes: immunoanalysis in the diagnosis of m… (10.1186/2044-5040-1-24)
Abstract ORCID License
119.33 38
50 Andrographolide attenuates skeletal muscle dystrophy in mdx… (10.1186/2044-5040-4-6)
Abstract ORCID License
118.48 37